Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Dementia

NHS ‘nowhere near ready’ to deliver new Alzheimer’s drug, doctors say

Patients unlikely to receive lecanemab before 2026 and health service does not yet have necessary infrastructure

The Guardian - UK

It’s just a first step, but this new Alzheimer’s drug could be a huge breakthrough

Recent lecanemab trials are reason for hope, although health services may struggle to deliver treatments, says dementia researcher Jonathan Schott

The Guardian - UK

Lecanemab: new Alzheimer’s drug hailed as ‘beginning of the end’ for disease

A ground-breaking drug has been found to slow cognitive decline in people with Alzheimer’s - with experts hailing it a breakthrough that “can meaningfully change the course of the disease”.

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

Breakthrough Alzheimer's drug hailed as 'beginning of the end' for treating disease

Lecanemab was found to have reduced memory decline by targeting and clearing amyloid, which is one of the proteins that build up in the brains of people with the disease

Daily Mirror

Simple urine test could be used to diagnose early-stage Alzheimer’s disease

The early stage of the disease occurs before the irreversible dementia stage and is the golden window for intervention and treatment

Wales Online

New Alzheimer’s drug hailed as 'beginning of the end' in quest for treatment

Clinical results suggest that the disease progression can by slowed by 27%

Wales Online

New Alzheimer’s drug hailed as ‘beginning of the end’ in search for treatment

Lecanemab was found to slow decline in patients’ memory and thinking.

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Scientists hail major breakthrough in fight against Alzheimer’s as drug proven to slow disease

‘This is the first drug that provides a real treatment option,’ says leading researcher

The Independent UK

Drug slows cognitive decline in Alzheimer’s patients, study reveals

Antibody therapy lecanemab removes clumps of protein called beta amyloid that builds up in brain

The Guardian - UK

Supreme Court case could curtail rights of Medicaid patients

Gorgi Talevski did not live long enough to see his case argued before the U.S. Supreme Court this month. A Macedonian-born resident of Indiana, Talevski operated a crane for three decades, raised a family and loved to dance before his dementia deepened, and he died last year.

Tribune News Service

Former St Mirren defender Barry McLaughlin welcomes new heading rules amid brain disease fears for players

The SFA have brought in new guidance to limit the amount of heading in training after research found footballers were more likely to suffer from brain disease in later life.

Daily Record

Family of Scots football hero Gordon McQueen back SFA crackdown on heading balls

The Manchester United powerhouse is now bedridden and unable to communicate after being diagnosed with vascular dementia last year.

Daily Record

SFA's new guidelines on restricting headers in football training are welcome

Record View says it has been heartbreaking in recent years to see many football legends have their lives cruelly blighted by dementia.

Daily Record

Council announces £60 million plans for care homes in RCT

It will involve creating extra care accommodation and dementia beds, closing three care homes, keeping five open and providing a care facility for adults with learning disabilities

Wales Online

Get all your
news in one place.

100's of premium titles.
One news app.

Wales Online

Five symptoms of dementia and the early warning signs to watch out for

One study has revealed that as many as one in four sufferers go at least two years before being diagnosed

Daily Mirror

Tony Robinson says UK care system is in chaos after looking after parents with dementia

More than 700,000 people in the UK are unpaid carers for those with dementia and tackle intractable problems all year round, but many soon face poverty and little or no respite

Daily Mirror

Real Britain: 'Our care system in chaos as those who depend on it face the consequences'

More than 700,000 people in the UK are unpaid carers for those with dementia and tackle intractable problems all year round, but many soon face poverty and little or no respite

The Conversation

Chris Hemsworth's Alzheimer's gene doesn't guarantee he'll develop dementia. Here's what we can all do to reduce our risk

Chris Hemsworth, famous for his role as the god Thor in Marvel Cinematic Universe movies, has announced he will be taking a break from acting after being told he has two copies of the APOE4 gene, increasing his risk of Alzheimer’s.

Get all your
news in one place.

100's of premium titles.
One news app.

Daily Mirror

Alzheimer's disease could be slowed down by new drug as NHS urged to speed up testing

Lecanemab could mark 'the end of the beginning' in the decades-long fight against dementia, geneticist Prof Sir John Hardy said. The drug was found to reduce brain decline in those with mild dementia

Daily Record

Love Actually star had to wear dead woman's clothes after friend stole £65k

Brian Malam had been granted power of attorney over Margaret Wright's finances after she was diagnosed with dementia, but spent years helping himself to cash.

The Independent UK

Breakthrough Alzheimer’s drug could be in UK use in a year but only for minority

Only 5% of patients eligible for the drug will be able to access it – and most of these will be private cases, experts have said.

The Independent UK

Five symptoms of dementia and early warning signs

One in four sufferers commonly go two years undiagnosed, one study claims

The National (Scotland)

Scottish dementia projects awarded £145,000 in funding

Dementia projects across Scotland have received funding to enable them to offer community- based support for people affected by the disease.

The Conversation

Another Alzheimer’s drug fails in late-stage trials – what now?

Around 55 million people, globally, have dementia – the most common type being Alzheimer’s disease. Unfortunately, there is no cure for the memory-robbing disease. But a lot of hope was pinned on an experimental drug called gantenerumab.

The Guardian - UK

‘This looks like the real deal’: are we inching closer to a treatment for Alzheimer’s?

After years of setbacks, dementia researchers are getting excited about a new antibody drug called lecanemab. No one expects it to stop cognitive decline, but even slowing it would be a breakthrough

1 … 100 101 102 103

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Alzheimer Research UK

152 stories

University of Glasgow

150 stories

Marvel Cinematic Universe

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.